Cosmos HoldingsCOSM
About: Cosmos Health Inc is engaged in the nutraceuticals sector through its own proprietary lines of products 'Sky Premium Life' and 'Mediterranation'. Additionally, the firm is operating in the pharmaceutical sector through the provision of a broad line of branded over-the-counter drugs and branded and generic medicines. The company's focus will be on Branded Pharmaceuticals, Over-the-Counter medicines, and Generic Pharmaceuticals. It provides its products to wholesale drug distributors, wholesalers, and retail healthcare providers. The company's segment are Wholesale, Pharma Manufacturing, Nutraceuticals & Pharmaceuticals and Other. It derives maximum revenue from Wholesale Segment.
Employees: 123
Fund manager confidence
Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)
242% more capital invested
Capital invested by funds: $615K [Q2] → $2.1M (+$1.49M) [Q3]
150% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 2
25% more funds holding
Funds holding: 12 [Q2] → 15 (+3) [Q3]
10.03% more ownership
Funds ownership: 3.49% [Q2] → 13.52% (+10.03%) [Q3]
0% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 3
Research analyst outlook
We haven’t received any recent analyst ratings for COSM.
Financial journalist opinion
Based on 4 articles about COSM published over the past 30 days
